LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome

NCT07234695 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Down Syndrome
Down Syndrome (DS)
Down Syndrome (Trisomy 21)
Alzheimer Dementia
Alzheimer Dementia (AD)
Alzheimer Disease
Alzheimer Disease (AD)
Alzheimer Blood Biomarkers
Epilepsy
Seizures

Interventions

DRUG: Levetiracetam 500mg
DRUG: Placebo

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]